Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTangible Book ValueTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Receivables (2022 - 2025)

Historic Receivables for NewGenIvf (NIVF) over the last 4 years, with Q3 2025 value amounting to $275.9 billion.

  • NewGenIvf's Receivables changed N/A to $275.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $275.9 billion, marking a year-over-year change of. This contributed to the annual value of $170797.0 for FY2024, which is 57500.69% up from last year.
  • Per NewGenIvf's latest filing, its Receivables stood at $275.9 billion for Q3 2025.
  • Over the past 5 years, NewGenIvf's Receivables peaked at $275.9 billion during Q3 2025, and registered a low of $25303.0 during Q4 2023.
  • Over the past 4 years, NewGenIvf's median Receivables value was $446254.0 (recorded in 2025), while the average stood at $65.0 billion.
  • Its Receivables has fluctuated over the past 5 years, first plummeted by 4159.18% in 2023, then surged by 19462157147.37% in 2024.
  • Quarter analysis of 4 years shows NewGenIvf's Receivables stood at $43321.0 in 2022, then plummeted by 41.59% to $25303.0 in 2023, then surged by 194621571.47% to $49.2 billion in 2024, then soared by 460.22% to $275.9 billion in 2025.
  • Its Receivables was $275.9 billion in Q3 2025, compared to $446254.0 in Q2 2025 and $49.2 billion in Q4 2024.